Log In
BCIQ
Print this Print this
 

Scintimun, besilesomab

  Manage Alerts
Collapse Summary General Information
Company Ion Beam Applications S.A.
DescriptionMurine mAb against carcinoembryonic antigen (CEA)-related cell adhesion molecule 8 (CEACAM8; NCA-95; CGM6; CD67)
Molecular Target Carcinoembryonic antigen (CEA)-related cell adhesion molecule 8 (CEACAM8) (NCA-95) (CGM6) (CD67)
Mechanism of ActionDiagnostic; Imaging agent; Antibody
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsScintigraphic imaging for determining the location of inflammation/infection in peripheral bone in adults with suspected osteomyelitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today